Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$25,035,872,397
+$2,379,502,666 QoQ
Shares Held
20,873,140
-15.3% QoQ
Ownership
2.22%
of shares outstanding
% of Portfolio
3.54%
of 13F equity value
Holder Rank
#7
of 4,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Research Global Investors holds $40,525,577,269 across 9 Drug Manufacturers - General names. LLY ranks #1 (61.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
20,873,140 | $25,035,872,397 | |
| 2 | ABBV |
AbbVie Inc.
|
30,101,551 | $7,574,754,293 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
19,393,296 | $2,450,149,016 | |
| 4 | AMGN |
Amgen Inc
|
6,272,625 | $2,271,442,965 | |
| 5 | JNJ |
Johnson & Johnson
|
8,164,545 | $2,073,549,493 | |
| 6 | AZN |
Astrazeneca PLC
|
4,197,587 | $795,946,446 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,925,013 | $247,364,170 | |
| 8 | SNY |
Sanofi
|
1,677,399 | $71,557,841 |
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,035,872,397 | 20,873,140 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $22,656,369,731 | 24,632,647 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $26,401,500,515 | 24,566,846 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $19,142,427,073 | 25,088,371 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $16,180,207,649 | 20,756,363 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $13,005,987,166 | 15,747,463 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $8,304,798,492 | 10,757,511 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,207,204,637 | 9,263,838 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,256,643,692 | 9,119,534 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,248,209,856 | 8,031,531 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,417,129,928 | 7,577,592 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,895,401,042 | 7,252,250 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,181,080,553 | 6,782,977 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,104,804,352 | 6,128,951 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,862,498,025 | 5,091,018 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,540,041,356 | 4,762,769 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $944,840,912 | 2,914,107 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||